Emergency Rule Related to Telemedicine

Posted in Latest News on May 6, 2014.

On March 12, 2014, Board of Medicine’s Rule 64B8-9.0141 went into effect wherein the Board set forth standards for telemedicine practice for Florida licensed physicians. Rule 64B8-9.0141(4) specifically precludes physicians from prescribing controlled substances through the use of telemedicine.

Shortly thereafter, the Board of Medicine began to receive reports from physicians and hospital representatives that expressed concern that the Board’s standards for telemedicine practice rule precludes physicians from ordering controlled substances through the use of telemedicine for their hospitalized patients. Rule 64B8-9.0141(4) precludes the prescribing of controlled substances through the use of telemedicine, but it was never the Board’s intent to preclude the use of telemedicine modalities to order controlled substances to hospitalized patients.

The aforementioned controlled substance prescribing prohibition has inadvertently created doubt amongst physicians about their ability to order controlled substances through the use of telemedicine for their hospitalized patients. This doubt likely arises from the lack of clear definition for the term “prescribing” as set forth Florida Statutes. Therefore, the Board of Medicine has filed a narrowly tailored emergency rule amending Rule 64B8-9.0141 to clarify that the ordering of controlled substances for hospitalized patients through the use of telemedicine is not precluded by Rule 64B8-9.0141(4).

This emergency, which goes into effect on April 30, 2014, is designed to prevent patient harm, does not harm licensees or any health care practitioners in any way, and most importantly clarifies the limited scope Rule 64B8-9.0141(4).



More Latest News

Massachusetts Special Commission on Pharmacy Compounding Report
June 12, 2013

In response to the tragic events of the multi-state meningitis outbreak Massachusetts Governor Patrick convened the Special Commission to investigate the oversight of compounding pharmacies. The report, which includes recommendations, was released in January 2013. The Florida Board of Pharmacy … Continue reading


DEA Guidelines to Prescription Fraud
June 12, 2013

Pharmacist’s Guide to Prescription Fraud The purpose of this guide is to ensure that controlled substances continue to be available for legitimate medical and scientific purposes while preventing diversion into the illicit market. It is not the intent of this … Continue reading